S. Aktürk Esen

The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

O. Avci, Mustafa YILMAZ, S. Paydaş, 2022, Anti-cancer drugs.

Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma

M. Dogan, O. Yazıcı, S. Kahraman, 2022, Journal of Oncological Sciences.

Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

M. Dogan, M. Yılmaz, O. Bal, 2020, Cureus.

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer

T. Kaçan, M. Karaağaç, S. Kılıçkap, 2022, Bosnian journal of basic medical sciences.

Ischemia-Modified Albumin and Thiol-Disulfide Homeostasis in Metastatic Pancreatic Cancer

Ö. Erel, I. Ateş, D. Uncu, 2022, Journal of Oncological Sciences.

Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer

Öznur Bal, D. Uncu, İ. Esen, 2020, Medicine.

Clinicopathologİcal Features and Survival Outcomes of 70 Tongue Squamous Cell Carcinoma Patients

S. Kahraman, E. Algın, Öznur Bal, 2022, Acta Oncologica Turcica.

Acute Urinary Retention and Acute Kidney Injury After Duloxetine Treatment: A Rare Case Report.

S. Kahvecioğlu, C. Gül, Nimet Aktaş, 2019, Journal of clinical psychopharmacology.

Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab.

G. Ucar, F. T. Köş, S. Aktürk Esen, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer

O. Bal, D. Uncu, Y. Açikgoz, 2021, Cureus.